Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MEDCAN GC01
- Development stage
- Unknown
- Lead developer
- Medcan Australia
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
MEDCAN GC01 is an oral medicinal cannabis capsule product developed by Medcan Australia. Each capsule contains 8 mg of delta-9-tetrahydrocannabinol (THC), the primary psychoactive constituent of the cannabis plant. THC acts as a partial agonist at cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2), which are G-protein coupled receptors involved in the endocannabinoid system. MEDCAN GC01 is available in Australia via the Therapeutic Goods Administration (TGA) Authorised Prescriber Scheme or Special Access Scheme (SAS Category A/B) for various medical applications, though it is not registered on the Australian Register of Therapeutic Goods (ARTG).
- Other names
- MEDCAN GC01 Cannabis CapsulesMedcan GC01
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on MEDCAN GC01.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MEDCAN GC01.